BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025)

BioNTech SE (BNTX) has 6 years of Other Non Operating Income data on file, last reported at -$452783.9 in Q2 2025.

• For the quarter ending Q2 2025, Other Non Operating Income rose 83.18% year-over-year to -$452783.9; the trailing twelve-month figure through Jun 2025 stood at -$33.5 million (down 194.48% YoY), and the FY2023 full-year result was $188.8 million, up 176.8% from the prior year.
• Other Non Operating Income climbed to -$452783.9 in Q2 2025, from -$27.3 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $121.6 million in Q2 2022 to a low of -$329.8 million in Q4 2022.
• A 5-year average of $2.8 million and a median of $8.3 million in 2021 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 312.29% in 2022, while the deepest fall reached 4161.05% in 2022.
• Tracing BNTX's Other Non Operating Income over 5 years: stood at $8.1 million in 2021, then plunged by 4161.05% to -$329.8 million in 2022, then soared by 93.08% to -$22.8 million in 2023, then jumped by 87.0% to -$3.0 million in 2024, then soared by 84.73% to -$452783.9 in 2025.
• Business Quant data shows BNTX's Other Non Operating Income at -$452783.9 in Q2 2025, -$27.3 million in Q1 2025, and -$3.0 million in Q3 2024.